Posttransplantation lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome

This publication has 37 references indexed in Scilit:

• Clinical characteristics of post-transplant lymphoproliferative disorders
  The American Journal of Medicine, 1994
• Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial
  Blood, 1994
• Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
  The Lancet, 1993
• Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders
  Blood, 1993
• Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients
  New England Journal of Medicine, 1990
• IMMUNOHISTOLOGY OF EPSTEIN-BARR VIRUS-ASSOCIATED ANTIGENS IN B CELL DISORDERS FROM IMMUNOCOMPROMISED INDIVIDUALS
  Transplantation, 1990
• The diagnosis and treatment of posttransplant lymphoproliferative disorders
  Current Problems in Surgery, 1988
• EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B CELL LYMPHOPROLIFERATION
  Transplantation, 1985
• Monoclonality of Lymphoproliferative Lesions in Cardiac-Transplant Recipients
  New England Journal of Medicine, 1984
• National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
  Cancer, 1982